159 related articles for article (PubMed ID: 23863598)
1. [A case of hyperammonemic encephalopathy related to 5-FU in an aged patient with recurrent colon cancer treated with FOLFIRI therapy].
Okamura T; Kawachi Y; Nikkuni K; Nishimura A; Makino S; Kawahara M; Kitami C; Hashimoto Y
Gan To Kagaku Ryoho; 2013 May; 40(5):671-3. PubMed ID: 23863598
[TBL] [Abstract][Full Text] [Related]
2. [A case of metastatic colorectal cancer with hyperammonemic encephalopathy induced by 5-FU in a patient continuously treated with XELOX therapy].
Nakano E; Kuroki M; Kanno N; Matsumura Y; Miura A; Kikuchi Y; Hirakawa H
Gan To Kagaku Ryoho; 2013 Dec; 40(13):2581-4. PubMed ID: 24335375
[TBL] [Abstract][Full Text] [Related]
3. [A case of hyperammonemia with encephalopathy related to FOLFIRI chemotherapy for advanced colon cancer].
Toyokawa A; Nakajima T; Inui K; Yamashita H; Gon H; Kanemitsu K; Tanaka K; Tsukamoto T; Hamabe Y; Ishida T
Gan To Kagaku Ryoho; 2009 Jul; 36(7):1167-9. PubMed ID: 19620810
[TBL] [Abstract][Full Text] [Related]
4. [A Case of Consciousness Disturbance Caused by Hyperammonemia during a mFOLFOX6 Regimen for Metastatic Colon Cancer].
Kagawa Y; Kato T; Naito A; Murakami K; Katsura Y; Ohmura Y; Okishiro M; Takeno A; Egawa C; Takeda Y; Tamura S
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2160-2. PubMed ID: 26805297
[TBL] [Abstract][Full Text] [Related]
5. [A Case Altered Consciousness Due to 5-Fluorouracil-Induced Hyperammonemia in a Patient with Recurrent Colorectal Cancer].
Sawazaki S; Numata M; Ju M; Morita J; Komori K; Maezawa Y; Amano S; Aoyama T; Tamagawa H; Sato T; Oshima T; Mushiake H; Yukawa N; Masuda M; Rino Y
Gan To Kagaku Ryoho; 2019 Oct; 46(10):1632-1634. PubMed ID: 31631158
[TBL] [Abstract][Full Text] [Related]
6. [A case of hyperammonemic encephalopathy in a patient with recurrent colon cancer treated with modified FOLFOX6].
Teraishi F; Suzuki T; Nakamoto M; Chikuba A; Nezu M; Shimamura H; Watanabe T; Matsuda T; Takiue T; Chikuba H
Gan To Kagaku Ryoho; 2009 May; 36(5):867-9. PubMed ID: 19461197
[TBL] [Abstract][Full Text] [Related]
7. The aggravating factors of hyperammonemia related to 5-fluorouracil infusion--a report of two cases.
Kikuta S; Asakage T; Nakao K; Sugasawa M; Kubota A
Auris Nasus Larynx; 2008 Jun; 35(2):295-9. PubMed ID: 17826933
[TBL] [Abstract][Full Text] [Related]
8. [A Case of Hyperammonemia Induced by Chemotherapy with 5-Fluorouracil for Metastatic Colon Cancer].
Tokuyama S; Fukunaga M; Konishi K; Honda S; Yukimoto R; Okamoto A; Saito A; Okada K; Ota H; Yokoyama S; Miki H; Kobayashi K
Gan To Kagaku Ryoho; 2018 Apr; 45(4):743-745. PubMed ID: 29650854
[TBL] [Abstract][Full Text] [Related]
9. [A case of metastatic colorectal cancer suffering from hyperammonemic encephalopathy induced by 5-FU, continuously treated with FOLFOX therapy].
Shoji H; Kuroki M; Hiramoto K; Matsumura Y; Miura A; Kikuchi Y; Hirakawa H
Gan To Kagaku Ryoho; 2010 Aug; 37(8):1583-6. PubMed ID: 20716892
[TBL] [Abstract][Full Text] [Related]
10. 5-Fluorouracil rechallenge after 5-fluorouracil-induced hyperammonemic encephalopathy.
Boilève A; Wicker C; Verret B; Leroy F; Malka D; Jozwiak M; Pontoizeau C; Ottolenghi C; De Lonlay P; Ducreux M; Hollebecque A
Anticancer Drugs; 2019 Mar; 30(3):313-317. PubMed ID: 30531368
[TBL] [Abstract][Full Text] [Related]
11. 5-FU-induced hyperammonemic encephalopathy in a case of metastatic rectal adenocarcinoid successfully rechallenged with the fluoropyrimidine analog, capecitabine.
Advani PP; Fakih MG
Anticancer Res; 2011 Jan; 31(1):335-8. PubMed ID: 21273620
[TBL] [Abstract][Full Text] [Related]
12. [Two cases of hyperammonemic patients treated by chemotherapy for colorectal cancer].
Aihara A; Terasawa M; Furukawa S; Kasai R; Ito T; Ochiai T; Kumagai Y; Iida M; Yamazaki S
Gan To Kagaku Ryoho; 2012 May; 39(5):839-42. PubMed ID: 22584345
[TBL] [Abstract][Full Text] [Related]
13. [A clinical case of recurrent small intestinal cancer successfully treated with FOLFOX6].
Fukunaga H; Endo W; Ota H; Yoshioka S; Hojo S; Fujie Y; Yoshioka A; Toyoda Y; Shimizu K; Maeura Y
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1972-4. PubMed ID: 23267947
[TBL] [Abstract][Full Text] [Related]
14. [Second-line FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer after resection of the primary lesion].
Abe H; Mafune K; Minamimura K; Abe M; Umemura A; Hirata T
Gan To Kagaku Ryoho; 2013 May; 40(5):601-4. PubMed ID: 23863581
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T).
Weissinger F; Reymond M; Dumke K; Krüger M
Onkologie; 2011; 34(10):548-51. PubMed ID: 21985855
[TBL] [Abstract][Full Text] [Related]
16. [A Case of Recurrent Hyperammonemic Encephalopathy during Adjuvant Chemotherapy(Modified FOLFOX6)for Colorectal Cancer].
Yoshino Y; Tamura A; Kagami S; Funahashi K
Gan To Kagaku Ryoho; 2018 Nov; 45(11):1665-1668. PubMed ID: 30449860
[TBL] [Abstract][Full Text] [Related]
17. [A case report of recurrent lung metastasis after surgery for rectal cancer for which lung radiofrequency ablation therapy and long-term administration of FOLFIRI were effective].
Suzuki N; Suzuki S; Tominaga K; Hoshino M; Naruse H; Fukushima M; Murakami M
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2267-9. PubMed ID: 23268045
[TBL] [Abstract][Full Text] [Related]
18. [Huge unresectable multiple hepatic metastases of rectum cancer responding to combined therapy with FOLFIRI +bevacizumab - a case report].
Tagami Y; Ogata S; Katakawa M; Bando Y
Gan To Kagaku Ryoho; 2012 Feb; 39(2):317-9. PubMed ID: 22333652
[TBL] [Abstract][Full Text] [Related]
19. [Hyperammonemic encephalopathy after treatment with modified FOLFOX6 regimen for recurrent gastric cancer:a case report].
Kuwabara S; Murakawa K; Kumagai K; Takeuchi Y; Wada H; Ichinokawa M; Matsumoto J; Ono K; Hirano S
Nihon Shokakibyo Gakkai Zasshi; 2022; 119(1):72-78. PubMed ID: 35022374
[TBL] [Abstract][Full Text] [Related]
20. [Considering Recurrence Prevention Regimen for Colorectal Cancer Patients with Hyperammonemia Caused by Chemotherapy Containing 5-Fluorouracil].
Aomatsu N; Tsujio G; Aomatsu K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1851-1853. PubMed ID: 38303229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
